Korea issues guidance on COVID‑19 treatment supply for nursing facilities and pharmacies

The Korean authorities have issued a notice to nursing institutions regarding the supply and use of COVID‑19 therapeutics as case numbers rise. Pharmacies are urged to review and secure sufficient quantities of Paxlovid to ensure timely dispensing. The use of 베클루리주 should be differentiated according to patient status and available supply. The notice, titled “Guidance on COVID‑19 treatments in response to increased patient occurrences,” was distributed by the KDCA’s Stockpile Management Division to nursing facilities and related parties to provide reference for prescribing and dispensing. The guidance aims to support appropriate allocation of limited therapeutic resources during the surge.